<?xml version="1.0" encoding="UTF-8"?>
<p>Whilst rare in comparison to other high burden diseases prevalent in this region, such as malaria (
 <xref rid="bib40" ref-type="bibr">Gething et al., 2011</xref>; 
 <xref rid="bib88" ref-type="bibr">Murray et al., 2012</xref>), Ebola outbreaks can have a considerable economic and political impact, and the subsequent destabilisation of basic health care provisioning in affected regions increases the toll of unrecorded morbidity and mortality of more common infectious diseases (
 <xref rid="bib87" ref-type="bibr">Murray et al., 2014</xref>; 
 <xref rid="bib131" ref-type="bibr">Wang et al., 2014</xref>), throughout and after the epidemic period. The number of concurrent infections during the present outbreak represents a significant strain on healthcare systems that are already poorly provisioned (
 <xref rid="bib14" ref-type="bibr">Briand et al., 2014</xref>; 
 <xref rid="bib19" ref-type="bibr">Chan, 2014</xref>; 
 <xref rid="bib30" ref-type="bibr">Fauci, 2014</xref>) and many other Set 1 and Set 2 countries rank amongst the lowest per capita healthcare spenders. These considerations should be paramount when international organizations debate the financing requirements for the improvement of healthcare needed in the region and the urgency with which new therapeutics and vaccines can be brought into production (
 <xref rid="bib12" ref-type="bibr">Brady et al., 2014</xref>; 
 <xref rid="bib44" ref-type="bibr">Goodman, 2014</xref>).
</p>
